Trial Profile
Evaluation of the efficacy of rosuvastatin in daily practice (TARGET)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2006
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms TARGET
- Sponsors AstraZeneca
- 21 Nov 2006 New trial record.